Stockreport

Taysha Gene Therapies: Breakthrough Rett Program With BLA Acceleration Potential [Seeking Alpha]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF The FDA granted it a Breakthrough Therapy Designation. Its pivotal REVEAL trial finalized with a 6-month interim that could accelerate a BLA submission. The new trial [Read more]